Xponance Inc. Lowers Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Xponance Inc. reduced its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH) by 36.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 13,478 shares of the company’s stock after selling 7,848 shares during the period. Xponance Inc.’s holdings in Molina Healthcare were worth $4,870,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in Molina Healthcare by 18.4% in the first quarter. Vanguard Group Inc. now owns 6,449,375 shares of the company’s stock valued at $2,151,448,000 after buying an additional 1,001,372 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of Molina Healthcare by 8.3% in the 3rd quarter. Wellington Management Group LLP now owns 3,395,040 shares of the company’s stock valued at $1,113,200,000 after acquiring an additional 259,474 shares during the last quarter. State Street Corp raised its position in shares of Molina Healthcare by 25.6% during the 1st quarter. State Street Corp now owns 2,457,008 shares of the company’s stock worth $819,633,000 after acquiring an additional 501,107 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Molina Healthcare by 10.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,374,111 shares of the company’s stock worth $783,979,000 after purchasing an additional 228,221 shares during the last quarter. Finally, FMR LLC boosted its holdings in Molina Healthcare by 1.0% in the third quarter. FMR LLC now owns 2,175,796 shares of the company’s stock valued at $713,422,000 after purchasing an additional 22,583 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Molina Healthcare Stock Up 1.8 %

Molina Healthcare stock opened at $367.52 on Friday. The stock has a 50 day moving average of $394.33 and a two-hundred day moving average of $370.95. Molina Healthcare, Inc. has a twelve month low of $266.35 and a twelve month high of $423.92. The stock has a market capitalization of $21.53 billion, a price-to-earnings ratio of 19.57, a PEG ratio of 1.03 and a beta of 0.47. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.57.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, February 7th. The company reported $4.38 EPS for the quarter, topping the consensus estimate of $4.31 by $0.07. Molina Healthcare had a return on equity of 32.34% and a net margin of 3.20%. The business had revenue of $9.05 billion during the quarter, compared to analysts’ expectations of $8.35 billion. During the same quarter in the prior year, the business earned $4.10 earnings per share. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. As a group, research analysts expect that Molina Healthcare, Inc. will post 23.62 earnings per share for the current year.

Insiders Place Their Bets

In other news, CFO Mark Lowell Keim sold 15,000 shares of the business’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the transaction, the chief financial officer now directly owns 36,531 shares in the company, valued at $14,121,423.36. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now directly owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard M. Schapiro sold 1,000 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total value of $401,050.00. Following the transaction, the director now directly owns 11,207 shares in the company, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. In the last quarter, insiders sold 16,711 shares of company stock worth $6,472,517. 1.10% of the stock is owned by insiders.

Wall Street Analyst Weigh In

MOH has been the subject of several recent analyst reports. Truist Financial boosted their price objective on shares of Molina Healthcare from $435.00 to $460.00 and gave the stock a “buy” rating in a research report on Tuesday, February 20th. Bank of America cut shares of Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 price target for the company. in a research report on Thursday, March 28th. StockNews.com lowered Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 8th. Wells Fargo & Company reduced their target price on Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating for the company in a report on Monday, April 15th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $406.00 price target on shares of Molina Healthcare in a research note on Thursday, April 4th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $393.09.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.